Pliant Therapeutics PLRX
NASDAQ PLRX
$0.86 0.00 (-0.20%)
At close: Oct 23, 2026 · 4:00 PM EDT

Pliant Therapeutics (PLRX) Cash & Current Investments (2019 - 2026)

Updated

Pliant Therapeutics' Cash & Current Investments came in at $158.1 million for Q2 2026, down 39.9% from $262.87 million a year earlier and down 7.5% from the prior quarter.

Analysis

Pliant Therapeutics (PLRX) Cash & Current Investments (2019 - 2026) Analysis & Trends

At the end of FY2025, Pliant Therapeutics' Cash & Current Investments was $190.94 million, down 46.3% from FY2024.

  • Cash & Current Investments carries a five-year compound annual growth rate of -7.2% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $355.72 million in FY2024 (-28.0%), $494.25 million in FY2023 (+49.2%), $331.19 million in FY2022 (+65.1%) and $200.6 million in FY2021 (-27.6%).
  • The Q2 2026 figure represents the lowest quarterly Cash & Current Investments since Q4 2019.
  • Year-over-year, Cash & Current Investments has declined for ten consecutive quarters, with an average decline of 37.2% over the last eight quarters.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q2 2023 (growth of 239.3%), and the weakest in Q4 2025 (a decline of 46.3%).
  • Business Quant data shows PLRX's Cash & Current Investments at $170.89 million (Q1 2026), $190.94 million (Q4 2025) and $241.8 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Pliant Therapeutics 53.25 Mn -708.48 Mn - 158.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 158.10 Mn
Mar 31, 2026 170.89 Mn
Dec 31, 2025 190.94 Mn
Sep 30, 2025 241.80 Mn
Jun 30, 2025 262.87 Mn
Mar 31, 2025 305.65 Mn
Dec 31, 2024 355.72 Mn
Sep 30, 2024 404.51 Mn
Jun 30, 2024 436.61 Mn
Mar 31, 2024 482.39 Mn
Dec 31, 2023 494.25 Mn
Sep 30, 2023 523.61 Mn
Jun 30, 2023 555.16 Mn
Mar 31, 2023 577.31 Mn
Dec 31, 2022 331.19 Mn
Sep 30, 2022 360.24 Mn
Jun 30, 2022 163.60 Mn
Mar 31, 2022 178.28 Mn
Dec 31, 2021 200.60 Mn
Sep 30, 2021 221.04 Mn
API Access

Pliant Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=PLRX&period=max&api_key=YOUR_API_KEY